Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Digital ACT Psychological Support for Primary Caregivers of Older Adults With Severe Mental Illness (DACT-Care)

6 de noviembre de 2026 actualizado por: Hao Zhang, Harbin Medical University

Development and Effectiveness Evaluation of a Digital ACT-Based Psychological Support Program for Primary Caregivers of Older Adults With Severe Mental Illness in Less Developed Regions

The goal of this clinical trial is to evaluate the effect of a digital Acceptance and Commitment Therapy (ACT)-based psychological support program for primary caregivers of older adults with severe mental disorders (SMD) in underdeveloped regions. It will also assess the feasibility and acceptability of this WeChat-mini-program-based intervention. The main questions it aims to answer are:

Does the digital ACT-based psychological support program improve psychological flexibility and family functioning among primary caregivers of older adults with SMD? Can this digital intervention improve psychological distress, perceived social support, caregiver needs-resources and disease-care-related knowledge for participating caregivers?

Researchers will compare digital ACT-based psychological support plus identical routine psychological support versus the same routine psychological support plus daily general mental-health and care-related popular-science reading materials to see whether the digital ACT program produces better outcomes.

Participants will:

Receive assigned 8-week study-related daily content on the basis of identical routine psychological support Complete online-or-paper-based questionnaires at baseline, immediately after intervention, and 1-month follow-up Take part in brief follow-up reminders via phone or WeChat during the study

Descripción general del estudio

Estado

Aún no reclutando

Condiciones

Intervención / Tratamiento

Descripción detallada

This is a single-center, parallel-group randomized controlled trial conducted in Tieli City, Yichun, Heilongjiang Province, China. A total of 64 eligible primary caregivers of older adults (≥60 years old) with severe mental disorders (SMD) will be enrolled and randomly assigned at a 1:1 ratio, with 32 participants in the intervention group and 32 participants in the control group. The sample-size calculation was performed using G*Power 3.1.9.7 for repeated-measures ANOVA (group-by-time interaction): effect size f = 0.25, α = 0.05, power (1-β) = 0.95, 2 groups, 3 measurement time-points. The calculated minimum analyzable sample size is 44 participants. A 30 % anticipated attrition rate was added, leading to the final recruitment target of 64 participants.

All participants in both groups will receive identical routine psychological support, including regular disease-related and care-related knowledge education and basic empathetic listening provided via telephone and WeChat three times per week.

Participants allocated to the intervention group will additionally receive an 8-week digital psychological support program based on Acceptance and Commitment Therapy (ACT), delivered through a lightweight WeChat mini-program. The ACT training module is the core component and consists of eight sequentially unlocked weekly sessions: an ACT introduction session using a choice-point tool to identify experiential avoidance, followed by acceptance, cognitive defusion, contacting the present moment, observing self, values clarification, and committed action, and a final session of review and consolidation. Each session combines short video or illustrated texts, scenario-based comprehension items and a guided self-reflection exercise. Scenario items are built on real caregiving situations and use neutral response options without negative feedback, in line with the accepting stance of ACT. The program delivers a pre-planned daily schedule consisting of six learning days and one weekly review day: each learning day requires approximately 7-8 minutes (a 2-minute optional daily emotion check-in plus 5-6 minutes of core learning content), and the weekly review day requires approximately 10 minutes of emotion-data review, knowledge consolidation and practice. Three supplementary modules can be used on demand without a fixed sequence: an emotion check-in module (daily emotion record, personal emotion calendar and structured emotional review), a caregiving skill workshop (management of acute relapse, medication refusal and hoarding, self-harm and suicide risk, aggressive behavior and emergency referral, routine home care skills, SMD knowledge education and scenario-based practice), and a resource navigation module (national, provincial, municipal and county-level mental health policies, local designated psychiatric facilities, welfare subsidies and medical insurance reimbursement procedures). Local grassroots staff will provide simple operational guidance and adherence reminders by phone or WeChat, without interpreting ACT professional content.

Participants in the control group will maintain the same daily contact frequency and overall time burden as the intervention group. General mental-health and care-related popular-science reading materials without any ACT-related or other psychological-regulation training content will be delivered via WeChat every day over the 8-week period, with reading duration (approximately 7-8 minutes per day) and total reading load matched to the daily learning volume of the intervention group. Participants only need to read the materials, with no homework, reflection tasks or interactive psychological exercises. Both groups receive no additional psychological treatment during the study period.

Outcome assessments will be performed at three time-points: baseline (T0, before randomization), immediately after completion of the 8-week intervention (T1), and one-month follow-up after intervention termination (T2). Questionnaires can be completed online via QR-code or using identical paper versions for participants with limited digital operation ability. The primary outcome is psychological flexibility measured by the Chinese version of the Comprehensive assessment of Acceptance and Commitment Therapy processes (CompACT), a 23-item instrument covering the dimensions of openness to experience, awareness and engaged action, scored on a 7-point Likert scale from 0 (never) to 6 (always), with higher total scores indicating greater psychological flexibility. Secondary outcomes include: family functioning measured by the Chinese revised Family Assessment Device (FAD), a 30-item scale covering affective involvement, positive communication, self-absorption, problem solving and family rules, scored on a 4-point Likert scale (total range 30-120, higher scores indicating better family functioning); psychological distress measured by the 12-item General Health Questionnaire (GHQ-12, Zhang Mingyuan Chinese version), a 12-item self-report screening instrument scored continuously; caregiver needs and resources measured by the Chinese version of the Caregiver Needs and Resources Assessment (CNRA), a 36-item instrument with two dimensions (needs and resources) across 12 domains, two reverse-scored items, scored on a 5-point Likert scale; disease- and care-related knowledge measured by an instrument adapted from the schizophrenia knowledge-attitude-practice awareness questionnaire, covering disease attribution, risk factors, treatment and social rehabilitation across 30 items and reworded for caregivers of older adults with SMD; and perceived social support measured by the Chinese version of the Perceived Social Support Scale (PSSS), a 12-item instrument covering family, friend and other support scored on a 7-point Likert scale. Objective system-usage logs (login frequency, module completion, learning-day adherence) and a self-reported satisfaction questionnaire will be collected to evaluate intervention feasibility and acceptability.

All adverse events and unanticipated problems reported by participants or identified through routine contact will be recorded and reported to the ethics committee. Participants are free to withdraw at any time without affecting their routine care.

After finishing all research assessments, participants in the control group will be granted full access to the digital ACT psychological support mini-program as a benefit for study participation.

Statistical analysis will follow modified intention-to-treat (mITT) and per-protocol (PP) principles. Generalized linear mixed models will be applied to examine group-by-time interaction effects for outcome indicators, with baseline values and covariates adjusted as appropriate. Missing data will be handled by multiple imputation, with sensitivity analysis conducted.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

56

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Hao Zhang, MSN
  • Número de teléfono: +8618945968922
  • Correo electrónico: 13227616120@163.com

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

Primary family caregiver of an older adult (≥60 years) with severe mental disorder, aged 18 years or older.

Having basic cognitive ability (Mini-Cog score of 3, or 1-2 with normal Clock Drawing Test) and basic reading ability.

Willing to participate and providing signed informed consent.

Exclusion Criteria:

Currently participating in another psychological intervention study, or having received structured psychological support within the past 3 months.

Family experienced a major adverse event within the past 6 months (such as bereavement, major financial crisis, or natural disaster).

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Doble

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: ACT digital intervention group

Participants receive a 4-week digital Acceptance and Commitment Therapy intervention. Daily 7-8 minutes fragmented ACT training for family caregivers of people with severe mental disorders.

An 8-week digital Acceptance and Commitment Therapy (ACT) intervention delivered via WeChat for family caregivers of people with severe mental disorders. It includes daily 7-8 minute fragmented ACT training modules covering acceptance, cognitive defusion, self-as-context, values, and committed action practice.

Comparador activo: Routine care control group

Participants receive routine care and general caregiver health education, without access to the ACT digital intervention.

Routine supportive care and general health education delivered through WeChat educational posts for family caregivers of people with severe mental disorders. Participants will not receive the 8-week digital ACT intervention.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Psychological flexibility
Periodo de tiempo: 12 weeks

Psychological flexibility was assessed using the Comprehensive Assessment of Acceptance and Commitment Therapy Processes (CompACT) questionnaire developed by Francis et al. This study employed the Chinese version translated by Fang et al. The scale consists of 23 items across three dimensions: Openness, Awareness, and Action. It uses a 7-point Likert scale ranging from "Never" to "Always," scored from 0 to 6, with higher total scores indicating a greater level of psychological flexibility

12 weeks

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Family function
Periodo de tiempo: 12 weeks

Family function assessed by the Family Assessment Device (FAD), comprising 30 items across five dimensions, scored on a 4-point Likert scale (30-120). Higher scores indicate better family function.

12 weeks
Caregiver Needs and Resources
Periodo de tiempo: 12 weeks

Caregiver needs and resources were assessed using the Caregiver Needs and Resources Assessment (CNRA) scale developed by Li et al. The scale consists of 36 items across two dimensions (Needs and Resources) and 12 domains, with 2 of the items being reverse-scored. It employs a 5- point Likert scale ranging from "Never" to "Extremely Much," scored from 1 to 5. Higher scores indicate more pronounced levels of the corresponding needs or resources.

12 weeks
Psychological distress
Periodo de tiempo: 12 weeks

Psychological distress measured by the 12-item General Health Questionnaire (GHQ-12), a self-report screening tool covering anxiety, depression, and impaired social functioning.

12 weeks

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Director de estudio: Quanzhi Zhang, PhD, Harbin Medical University

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de marzo de 2027

Finalización primaria (Estimado)

1 de julio de 2027

Finalización del estudio (Estimado)

1 de septiembre de 2027

Fechas de registro del estudio

Enviado por primera vez

6 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

6 de noviembre de 2026

Publicado por primera vez (Actual)

12 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

12 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

6 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • HMUDQ20251221001

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .